Sharemaestro company-news research for Wolters Kluwer N.V. (WKL), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

AMS Netherlands Measured evidence

Company news sentiment

WKL news sentiment

Wolters Kluwer N.V.

Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.

Weighted tone58Neutral is 50
Constructive news tone 54/100 evidence confidence 100% direct company focus 2 current stories across 1 publishers
Latest weekly closeEUR 69.90week of 7 Aug 2026
Dominant catalystMarket update75/100 classification confidence
News data statusHealthy0 duplicate stories removed

Current company news

News confirmed by price

Constructive news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.

Latest source headline Wolters Kluwer Brings Trusted Medi-Span Medication Intelligence to Growing Veterinary Drug Market finance.yahoo.com · 11 Aug 2026 13:30

What supports the read

Direct evidence

2 current stories are mapped specifically to WKL.

Narrative agreement

Cross-story agreement is 96/100, indicating a comparatively coherent tape.

Price response

Constructive news tone is being confirmed by positive weekly price action.

What tempers the read

Source breadth

Only 1 publisher currently contribute to the measured read.

58/100
Weighted toneConstructive news tone
54/100
Evidence confidencebuilding confidence
100%/100
Company focus2 direct stories
96/100
Evidence agreement4/100 dispersion

News history

Tone and story flow over 21 days

Daily weighted evidence
11 Aug: 2 stories 11 Aug: tone 66, 2 stories 95505
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50

Evidence confidence

What supports the score

Measured separately from tone

Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.

Sample depth25
2.0 effective stories
Source breadth20
1 independent publishers
Direct relevance100
company-specific evidence share
Freshness77
recency-weighted evidence
Agreement96
cross-story consistency
Source independence0
lower publisher concentration

Price context

Sentiment against the 26-week price path

News confirmed by price

Constructive news tone is being confirmed by positive weekly price action.

13 Feb 2026: close 62.55, indexed 100.020 Feb 2026: close 60.77, indexed 97.227 Feb 2026: close 66.37, indexed 106.106 Mar 2026: close 66.78, indexed 106.813 Mar 2026: close 65.55, indexed 104.820 Mar 2026: close 63.78, indexed 102.027 Mar 2026: close 60.73, indexed 97.103 Apr 2026: close 63.66, indexed 101.810 Apr 2026: close 61.09, indexed 97.717 Apr 2026: close 69.53, indexed 111.224 Apr 2026: close 64.73, indexed 103.501 May 2026: close 64.73, indexed 103.508 May 2026: close 60.33, indexed 96.415 May 2026: close 59.66, indexed 95.422 May 2026: close 60.91, indexed 97.429 May 2026: close 61.02, indexed 97.605 Jun 2026: close 63.48, indexed 101.512 Jun 2026: close 61.1, indexed 97.719 Jun 2026: close 58.86, indexed 94.126 Jun 2026: close 57.0, indexed 91.103 Jul 2026: close 57.62, indexed 92.110 Jul 2026: close 60.5, indexed 96.717 Jul 2026: close 61.78, indexed 98.824 Jul 2026: close 62.46, indexed 99.931 Jul 2026: close 67.86, indexed 108.507 Aug 2026: close 69.9, indexed 111.8 20 Jun 2026: sentiment 4920 Jun 2026: sentiment 5121 Jun 2026: sentiment 5021 Jun 2026: sentiment 5121 Jun 2026: sentiment 5121 Jun 2026: sentiment 5122 Jun 2026: sentiment 5122 Jun 2026: sentiment 5122 Jun 2026: sentiment 5122 Jun 2026: sentiment 5122 Jun 2026: sentiment 5122 Jun 2026: sentiment 5123 Jun 2026: sentiment 5126 Jun 2026: sentiment 5027 Jun 2026: sentiment 5127 Jun 2026: sentiment 5227 Jun 2026: sentiment 5227 Jun 2026: sentiment 5128 Jun 2026: sentiment 5130 Jun 2026: sentiment 5103 Jul 2026: sentiment 5103 Jul 2026: sentiment 5107 Jul 2026: sentiment 5007 Jul 2026: sentiment 5013 Jul 2026: sentiment 5118 Jul 2026: sentiment 5022 Jul 2026: sentiment 5122 Jul 2026: sentiment 5123 Jul 2026: sentiment 5224 Jul 2026: sentiment 5224 Jul 2026: sentiment 5225 Jul 2026: sentiment 5330 Jul 2026: sentiment 5202 Aug 2026: sentiment 5111 Aug 2026: sentiment 51
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price+11.8%latest close 69.9
Sentiment change+2available snapshot window
One-week response+3.0%Price confirming higher
Fair-value position-41.0%Below fair value
Sentiment-trend disagreementMarket Dynamics buy signalValue support

News subjects

What is shaping the score

Market update
Market update662 stories · 100%

Source mix

Where the evidence comes from

0/100 independence
finance.yahoo.com662 stories · 100%

Recurring subjects

Subjects appearing most often

Current evidence
Veterinary Medicine1Software1Pharmacy Technology1Medication Safety1Financials1Data Management1Corporate Performance1

Earlier readings

How the score has changed

50 is the neutral baseline
ConstructiveBalanced or withheldCautious

Source headlines

The news behind the score

Showing 1-2 of 2

Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.

#162Tone
finance.yahoo.comDirect company coverage

Wolters Kluwer Brings Trusted Medi-Span Medication Intelligence to Growing Veterinary Drug Market

WK survey finds three out of four pet owners want pet prescriptions from their retail pharmacy, creating new growth opportunities for pharmacies and pharmacy technology providers WALTHAM, Mass., August 11, 2026--(BUSINESS WIRE)--Wolters Kluwer Health today announced the availability of Medi-Span® Vet Meds, an embedded drug data and screening solution to help U.S. pharmacies seamlessly expand to serve pet owners by providing veterinary prescriptions at the same place where they pick up their own medications. Built specifically for retail pharmacies, pharmacy partners, and veterinary medication

Medication SafetyPharmacy TechnologyVeterinary Medicine
Published
11 Aug 2026 13:30
Catalyst
Market update
Evidence role
Direct company coverage
Duplicates
1 consolidated
#270Tone
finance.yahoo.comDirect company coverage

Wolters Kluwer Enables Longcheer to Drive Finance Transformation With CCH Tagetik

CCH Tagetik accelerates financial close by 33%, reduces manual workload by 80%, and enables end‑to‑end strategy‑to‑execution performance management MUMBAI, India, August 11, 2026--(BUSINESS WIRE)--Wolters Kluwer, a global leader in professional information, software solutions and services, today announced the successful go live of the CCH® Tagetik Corporate Performance Management (CPM) platform at Longcheer, a global leader in intelligent products and services. The implementation establishes a unified, finance driven digital platform spanning group consolidation, financial planning and analysi

Corporate PerformanceData ManagementFinancialsSoftware
Published
11 Aug 2026 13:00
Catalyst
Market update
Evidence role
Direct company coverage
Duplicates
1 consolidated

How the page works

How to read the score

Tone is directional

It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

Classification, not prediction

The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.

Evidence context